Cytochrome P450 2D6 Activity Predicts Discontinuation of Tamoxifen Therapy in Breast Cancer Patients

The selective estrogen receptor modulator tamoxifen is routinely used for treatment and prevention of estrogen receptor positive breast cancer. Studies of tamoxifen adherence suggest that over half of patients discontinue treatment before the recommended 5 years. We hypothesized that polymorphisms i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rae, James M., Sikora, Matthew J., Henry, N. Lynn, Li, Lang, Kim, Seongho, Oesterreich, Steffi, Skaar, Todd, Nguyen, Anne T., Desta, Zeruesenay, Storniolo, Anna Maria, Flockhart, David A., Hayes, Daniel F., Stearns, Vered
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2991048/
https://ncbi.nlm.nih.gov/pubmed/19421167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2009.14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados